Cargando…

Immuno-PET imaging based radioimmunotherapy in head and neck squamous cell carcinoma model

The epidermal growth factor receptor (EGFR) is one of the most comprehensively studied molecular targets in head and neck squamous cell carcinoma (HNSCC). However, inherent and acquired resistance are serious problems and are responsible for limited clinical efficacy and tumor recurrence. In this st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, In Ho, Noh, Youn, Kwon, Junhye, Jung, Jae Ho, Lee, Byung Chul, Kim, Kwang Il, Lee, Yong Jin, Kang, Joo Hyun, Rhee, Chae Seo, Lee, Chul Hee, Lee, Tae Sup, Choi, Ik Joon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696166/ https://www.ncbi.nlm.nih.gov/pubmed/29190900 http://dx.doi.org/10.18632/oncotarget.20760

Ejemplares similares

Combination Radioimmunotherapy Approaches and Quantification of Immuno-PET
por: Kim, Jin Su
Publicado: (2016)

Tissue Factor‐Targeted ImmunoPET Imaging and Radioimmunotherapy of Anaplastic Thyroid Cancer
por: Wei, Weijun, et al.
Publicado: (2020)

Radioimmunotherapy in HPV-Associated Head and Neck Squamous Cell Carcinoma
por: Zhou, Xin, et al.
Publicado: (2022)

PET Imaging Biomarkers of Anti-EGFR Immunotherapy in Esophageal Squamous Cell Carcinoma Models
por: Lee, Tae Sup, et al.
Publicado: (2018)

MiR-338-5p enhances the radiosensitivity of esophageal squamous cell carcinoma by inducing apoptosis through targeting survivin
por: Park, Misun, et al.
Publicado: (2017)

Copper-64-Labeled Antibody Fragments for Immuno-PET/Radioimmunotherapy with Low Renal Radioactivity Levels and Amplified Tumor-Kidney Ratios
por: Suzuki, Hiroyuki, et al.
Publicado: (2021)

The role of (18)F-FDG PET/CT in patients with diffuse large B-cell lymphoma after radioimmunotherapy using (131)I-rituximab as consolidation therapy
por: Choi, Joon Ho, et al.
Publicado: (2022)

(124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy
por: Tijink, Bernard M., et al.
Publicado: (2009)

A pretargeting system for tumor PET imaging and radioimmunotherapy
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2015)

Measurement of Tumor Pressure and Strategies of Imaging Tumor Pressure for Radioimmunotherapy
por: Kim, Hyeon-gi, et al.
Publicado: (2019)

Modulators of Ion Transport in Nasal Polyps: An in situ Measurement of Short-Circuit Current
por: Lee, Jun Ho, et al.
Publicado: (2008)

XPD Polymorphisms and Risk of Squamous Cell Carcinoma of the Head and Neck in a Korean Sample
por: Ji, Yong Bae, et al.
Publicado: (2010)

Combination Radioimmunotherapy Strategies for Solid Tumors
por: Zaheer, Javeria, et al.
Publicado: (2019)

Role of Angiogenic Factors in Airway Remodeling in an Allergic Rhinitis Murine Model
por: Moon, Il Joon, et al.
Publicado: (2012)

Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRIT(R))
por: De Santis, R, et al.
Publicado: (2003)

The Impact of Engorged Vein within Traumatic Posterior Neck Muscle Identified in Preoperative Computed Tomography Angiography to Estimated Blood Loss during Posterior Upper Cervical Spine Surgery
por: Ha, Mahn Jeong, et al.
Publicado: (2016)

Early prediction of neoadjuvant chemotherapy response for advanced breast cancer using PET/MRI image deep learning
por: Choi, Joon Ho, et al.
Publicado: (2020)

Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors
por: Rousseau, Caroline, et al.
Publicado: (2011)

Radioimmunotherapy for solid tumors: spotlight on Glypican-1 as a radioimmunotherapy target
por: Sabanathan, Dhanusha, et al.
Publicado: (2021)

FDG-PET/CT as prognostic factor and surveillance tool for postoperative radiation recurrence in locally advanced head and neck cancer
por: Kim, Giwon, et al.
Publicado: (2011)

Immuno-oncology in head and neck squamous cell carcinoma - a narrative review
por: da Silva, A.T., et al.
Publicado: (2023)

Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab
por: Muylle, Kristoff, et al.
Publicado: (2015)

Celecoxib-Induced Modulation of Colon Cancer CD133 Expression Occurs through AKT Inhibition and Is Monitored by (89)Zr Immuno-PET
por: Jung, Kyung-Ho, et al.
Publicado: (2022)

Usefulness of Integrated PET/MRI in Head and Neck Cancer: A Preliminary Study
por: Lee, Soo Jin, et al.
Publicado: (2013)

Immunostimulatory effects of radioimmunotherapy
por: Constanzo, Julie, et al.
Publicado: (2022)

Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
por: Gerretsen, M., et al.
Publicado: (1992)

Diagnostic Accuracy and Confidence of [18F] FDG PET/MRI in comparison with PET or MRI alone in Head and Neck Cancer
por: Park, Jisang, et al.
Publicado: (2020)

Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (Head and neck cancer: ImmunoChemo and Radiotherapy with Erbitux) – a multicenter phase IV trial
por: Habl, G, et al.
Publicado: (2013)

Cysteine-specific (89)Zr-labeled anti-CD25 IgG allows immuno-PET imaging of interleukin-2 receptor-α on T cell lymphomas
por: Lee, Jin Hee, et al.
Publicado: (2022)

Tumor-Associated Mast Cells in Urothelial Bladder Cancer: Optimizing Immuno-Oncology
por: Choi, Hae Woong, et al.
Publicado: (2021)

Immuno-PET for Clinical Theranostic Approaches
por: Bailly, Clément, et al.
Publicado: (2016)

Imaging PD-L1 Expression with ImmunoPET
por: Truillet, Charles, et al.
Publicado: (2017)

Relationship between Shift Type and Voluntary Exercise Training in South Korean Firefighters
por: Park, Seiyeong, et al.
Publicado: (2020)

The Prediction of HER2-Targeted Treatment Response Using (64)Cu-Tetra-Azacyclododecanetetra-Acetic Acid (DOTA)-Trastuzumab PET/CT in Metastatic Breast Cancer: A Case Report
por: Lee, Inki, et al.
Publicado: (2022)

Zr-89 Immuno-PET Targeting Ectopic ATP Synthase Enables In-Vivo Imaging of Tumor Angiogenesis
por: Park, Bok-Nam, et al.
Publicado: (2019)

Pretargeted Molecular Imaging and Radioimmunotherapy
por: Goldenberg, David M., et al.
Publicado: (2012)

Radioimmunotherapy: a brief overview
por: Ng, DCE
Publicado: (2006)

Is radioimmunotherapy a 'magic bullet'?
por: Kim, Sung-Hyun
Publicado: (2012)

Improvement of Radioimmunotherapy Using Pretargeting
por: Frampas, Eric, et al.
Publicado: (2013)

Trial Watch: Anticancer radioimmunotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4djthdua13s3426aedabi1nkq4